Previous Article | Next Article 
Molecular and Cellular Biology, December 2000, p. 8815-8825, Vol. 20, No. 23
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Asg7p-Ste3p Inhibition of Pheromone Signaling:
Regulation of the Zygotic Transition to Vegetative
Growth
Amy F.
Roth,1
Bryce
Nelson,2
Charlie
Boone,2 and
Nicholas
G.
Davis3,*
Department of Surgery1
and Departments of Surgery and
Pharmacology,3 Wayne State University School
of Medicine, Detroit, Michigan 48201, and Banting and Best
Department of Medical Research, University of Toronto, Toronto,
Ontario, Canada M5G 1L62
Received 28 June 2000/Returned for modification 22 August
2000/Accepted 15 September 2000
 |
ABSTRACT |
The inappropriate expression of the a-factor pheromone receptor
(Ste3p) in the MATa cell leads to a striking inhibition of the yeast pheromone response, the result of a functional interaction between Ste3p and some MATa-specific protein. The present
work identifies this protein as Asg7p. Normally, expression of Ste3p and Asg7p is limited to distinct haploid mating types, Ste3p to MAT
cells and Asg7p to MATa cells.
Artificial coexpression of the two in the same cell, either a or
,
leads to dramatic inhibition of the pheromone response. Ste3p-Asg7p
coexpression also perturbs the membrane trafficking of Ste3p: Ste3p
turnover is slowed, a result of an Asg7p-mediated retardation of the
secretory delivery of the newly synthesized receptor to the plasma
membrane. However, in the absence of ectopic Ste3p expression, the
asg7
mutation is without consequence either for
pheromone signaling or overall mating efficiency of a cells. Indeed,
the sole phenotype that can be assigned to MATa
asg7
cells is observed following zygotic fusion to its
mating partner. Though formed at wild-type efficiency, zygotes from
these pairings are morphologically abnormal. The pattern of growth is
deranged: emergence of the first mitotic bud is delayed, and, in its
place, growth is apparently diverted into a novel structure
superficially resembling the polarized mating projection characteristic
of haploid cells responding to pheromone. Together these results
suggest a mechanism in which, following the zygotic fusion event, Ste3p
and Asg7p gain access to one another and together act to repress the
pheromone response, promoting the transition of the new diploid cell to
vegetative growth.
 |
INTRODUCTION |
Sexual identity in the yeast
Saccharomyces cerevisiae is controlled by the MAT
locus. Transcriptional activators and repressors encoded by
MATa or MAT
alleles control the
expression of a limited number of cell type-specific gene products that
distinguish the two haploid mating types, the a cell and the
cell (24, 31). Chief among the cell type-specific
products expressed is a receptor-ligand system which is used to direct
the mating of the a and the
cells to form the
a/
diploid. The a cell secretes the
farnesylated peptide a-factor and expresses at its surface
the
-factor receptor (Ste2p), a G protein-coupled receptor which
confers detection of the
-factor peptide specifically produced and
secreted by the
cell. Likewise, the
cell expresses a distinct G
protein-coupled receptor, the a-factor receptor (Ste3p),
which detects the a-factor secreted by the a cell.
This system of pheromones and receptors enables the communication of
mating (for reviews, see references 18 and
19). Detection of pheromone alerts the cell to the
proximity of a potential mating partner and prepares the cell for
conjugation both through transcriptional induction of mating genes and
through arrest of the cell cycle in G1 at Start. Through
polarized growth of the cell body, the two mating partners extend
mating projections towards one another. The tips of the mating
projections meet, cells adhere to one another, and, with the joining of
the cell walls, the prezygote is formed. Finally, with dissolution of
the intervening cell walls and subsequent fusion of cytoplasms and
nuclei, the diploid zygote is formed: a cell with a characteristic
dumbbell morphology, having two terminal bulbs derived from the cell
bodies of the two haploid mating partners connected via a conjugation
bridge derived from the tip-to-tip fusion of the two mating projections.
The mating process culminates with the transition of the new diploid
cell to vegetative growth: the cells transition from G1 to
S, DNA replication is initiated, and a first mitotic bud begins to
emerge from the midpoint of the zygotic conjugation bridge. Prior to
zygote formation, during mating, pheromone signaling activates the cell
cycle kinase inhibitor protein Far1p, which binds to and inhibits the
Cdc28/Cln cell cycle kinase, and thus causes G1 arrest. The
reinitiation of the mitotic cycle for the new diploid cell requires
that this inhibition be relieved.
The STE3DAF mutation is a STE3
promoter mutation which confers cell type-independent expression of the
a-factor receptor (Ste3p) (13). With this mutant
it was found that the inappropriate expression of Ste3p in the
a cell context leads to a striking inhibition of the
pheromone signal transduction pathway, apparently exerted at the level
of the G
component of the heterotrimeric G protein,
i.e., the first postreceptor signaling step (6, 13, 17).
Inhibition depends on Ste3p and at least one
MATa-specific gene product that is neither
a-factor nor Ste2p (13). As Ste3p and the
hypothetical a-specific interactor normally reside in
different cell types, the biological relevance of this striking
interaction has remained a mystery. Kim et al. (17) have
suggested that Ste3p and its a cell interactor may gain
access to one another in the zygote following fusion of the two mating
partners and that the resulting inhibition of the pheromone response
could serve to promote the transition of the zygote into a vegetative
mode of growth. The present work identifies the a-specific Ste3p interactor as Asg7p and provides evidence which suggests that the
inhibition of the pheromone response provided by Ste3p-Asg7p may indeed
play a role in promoting the transition of the zygote to vegetative growth.
 |
MATERIALS AND METHODS |
Plasmids.
The LEU2 CEN ARS pRS315-derived plasmid
pND541 expresses an N-terminally hemagglutinin (HA)-tagged Ura3p from
the GAL1 promoter. Construction of pND541 first required
fusion of an 820-bp GAL1,10 promoter fragment to
the PstI site just upstream of the URA3 open reading frame (ORF). A restriction site for XhoI was then
introduced by oligonucleotide-directed mutagenesis between codons 3 and
4 of the URA3 ORF (the introduced sequence translates to the
dipeptide Leu-Glu). Finally, a DNA duplex encoding a single copy of the HA epitope, creating by annealing the two oligonucleotides
5'-pTCGAGTACCCATACGATGTTCCAGATTACGCTG-3' and
5'-pTCGACAGCGTAATCTGGAACATCGTATGGGTAC-3' was introduced into the XhoI site.
The wild-type ASG7 gene was isolated from a YCp50-based
yeast genomic library (25) through complementation of the
asg7
::G418R allele of
GAL1-STE3 GAL1-STE4 MATa strain NDY1050, isolating transformants capable of growth on galactose plates. The isolated library plasmid pND978 carries a 12-kb insert of genomic DNA that includes the ASG7 locus. To construct pND997, a 950-bp
ADH1 promoter fragment isolated from pLexA (Clontech
Laboratories, Inc., Palo Alto, Calif.) was inserted upstream of a
3.2-kb ASG7 ORF-containing fragment from pND978 carried on
URA3 CEN ARS vector pRS316 (30). ADH1
and ASG7 sequences were fused through ligation at
BamHI restriction sites introduced by oligonucleotide
mutagenesis into the two sequences at positions 35 bp upstream of the
initiator ATG codons for both ORFs. Plasmid p2664 carries the coding
sequence for a green fluorescent protein (GFP)-Ras2 fusion construct
(34) on the 2 µm LEU2 vector plasmid YEplac181
(12).
Strains.
The strains used are listed in Table
1. The
asg7
::G418R disruption
allele, which replaces the entire ASG7 ORF with the
G418R marker from plasmid pFA-kanMX, was
generated by PCR as described previously (33). The
fus1
::URA3 allele of plasmid
construct pSL671 and the fus2
::URA3
allele of p268 (complete descriptions of these plasmids are available
from C. Boone upon request) were used to chromosomally transplace
wild-type FUS1 and FUS2 alleles, respectively.
Most of the other strains constructed for this work utilized the
two-step gene replacement strategy (29) as previously
described (27). Many of these integrating plasmid constructs
used for these replacements have been described previously, including
replacement of MFA2 by
mfa2
::FUS1-LacZ (14),
replacement of RAD16 by
rad16::GAL1-STE4 (14),
replacement of BAR1 by bar1
(14),
and finally replacement of STE3 by either
ste3
::LEU2 (27),
GAL1-STE3 (26), or GAL1-STE3
365 (10).
Several additional gene replacement plasmids were constructed for the
present work. The integrating plasmid for
ste4
::LEU2, pND1103, derives from
pRS306 (30), having a functional LEU2 fragment
replacing an internal, 605-bp HindIII fragment of
STE4. Chromosomal integration was directed by cleavage at a
unique XhoI site within the remaining C-terminal portion of
the STE4 ORF sequence. For construction of the
lys2::FUS1-LacZ integrating plasmid, a 6.7-kb PstI-to-SalI FUS1-LacZ fragment
from pSL553 (14) having the PstI end modified by
an added KpnI linker was inserted into a 4.8-kb
EcoRI-HindIII LYS2 fragment
between a KpnI site and an XhoI site, 1.14 and
2.87 kb downstream of the LYS2 initiator ATG. Chromosomal
integration utilized cleavage at a unique BglII site within
sequences upstream of LYS2. The
ASG7::ADH1-ASG7 gene replacement construct, carried on URA3 integrating plasmid pRS306
(30), is derived from pND997 through introduction of a
3.6-kb fragment of ASG7 upstream flanking sequence from
pND978. In the resulting construct the 950-bp ADH1 promoter
fragment replaces the putative ASG7 promoter element
(removing sequences 420 to 35 bp upstream of the ASG7
initiator codon). Chromosomal integration of this construct into
asg7
::G418R strains was
directed by cleavage at a unique XhoI site located just
downstream of the ASG7 ORF.
NDY1176 and NDY1178, are the a/
diploid products of
matings of MAT
GAL1-STE3
365 strain NDY349 with
wild-type MATa strain W303-1A or with MATa
ADH1-ASG7 strain NDY1171, respectively. The
/
diploid
strains NDY1185 and NDY1186 were derived from NDY1176 and NDY1178,
respectively, via HO-mediated mating type switching.
Ste3p turnover.
Ste3p turnover was monitored via a
nonradioactive pulse-chase protocol as previously described
(26). Briefly, a pulse of Ste3p synthesis was induced from
GAL1-STE3 strains with the addition of galactose (2%) to
cultures growing in yeast extract-peptone (YP)-raffinose (2%) medium.
The chase period was initiated with the addition of glucose (3%), and,
at various times thereafter, culture aliquots were removed for protein
extract preparation (26). Extracts were subjected to sodium
dodecyl sulfate-polyacrylamide gel electrophoresis and then Western
analysis with affinity-purified rabbit polyclonal Ste3p-specific
antibodies (28) or with the HA.11 monoclonal antibody
(Berkeley Antibody Co., Berkeley, Calif.).
-Galactosidase assays.
FUS1-LacZ bar1
MATa
cells were cultured in YP-galactose (2%) medium and then treated with
different concentrations of
-factor for 1 h. Culture aliquots
were collected by centrifugation, cells were permeabilized, and
-galactosidase activity was determined as described previously
(15).
Protease digestion of intact cells.
The treatment of whole
cells with pronase (Calbiochem-Novabiochem Corp., La Jolla, Calif.) and
subsequent extract preparation were as described previously
(7).
Matings.
For quantitation of mating, aliquots containing
approximately 106 cells taken from log-phase cultures of
MATa and MAT
strains were mixed together
and then applied, under gentle vacuum pressure, as an approximately
1-cm-diameter spot onto a 2.5-cm-diameter, 0.45-µm-pore-size
nitrocellulose filter (Millipore, Inc.). The filter was then
transferred to a 30°C yeast extract-peptone-dextrose (YPD) plate and
incubated for 3 h. Cells were then eluted from filters with 1 ml
of synthetic dextrose medium, subjected to a 3-s sonication at the
lowest power setting of a Branson Sonifier 450, and then immediately
diluted and plated onto medium selective for the diploid cells. For the
microscopic inspection of zygotic and prezygotic morphology, matings
were performed as described above except that 107 cells of
the two mating partners were applied to filters, filters were incubated
on YPD plates at 30°C for various times, and then cells were eluted
with 1 ml of 0.15 M NaCl-3.7% formaldehyde and stored at 4°C prior
to analysis.
 |
RESULTS |
Impaired Ste3p turnover in MATa cells.
The yeast
a-factor receptor (Ste3p) is rapidly turned over via an
endocytic mechanism that transports the receptor from the cell surface
to the vacuole for degradation by the resident proteases
(7). In its normal MAT
cell context, the Ste3p
turnover half-life is about 15 min whether the protein is expressed
from its natural
-cell-specific promoter (7) or from the
GAL1 promoter (Fig. 1)
(26). We find a different result for Ste3p ectopically expressed in the MATa context (Fig. 1). Quantification of the rate of this Ste3p loss indicates that turnover is indeed slowed
in the a cell context relative to that in
cells (data
not shown), indicating either that some
-specific protein(s) acts to
augment Ste3p turnover or, alternatively, that an a-specific gene product somehow interferes with the Ste3p turnover mechanism. In
the a/
diploid cell context, we find rapid Ste3p turnover equivalent to that seen in
cells (data not shown), suggesting that
the slowed turnover of a cells likely is the result of
interference by some a-specific gene product.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 1.
Slowed Ste3p turnover in MATa cells
responding to pheromone. Turnover of Ste3p was monitored in three
isogenic yeast strains carrying a GAL1-STE3 construct in
place of the wild-type STE3 locus: the wild-type
MAT strain NDY1132, the wild-type MATa
strain NDY1140, and the mfa1 mfa2 MATa strain
SY2555. In addition, strains were transformed by pND541, a plasmid
which expresses an HA-tagged Ura3p from the GAL1 promoter. A
3-h period of Ste3p and HA-Ura3p expression was induced from cultures
growing in raffinose medium with the addition of galactose and
subsequent termination by glucose addition. One of two SY2555 cultures
was treated with two doses of -factor: a dose of 6 × 10 6 M administered 30 min prior to glucose addition and a
dose of 15 × 10 5 M administered 30 min after the
glucose addition. Protein extracts were prepared from culture aliquots,
removed at the time of glucose addition (0-h time point) and at
indicated times thereafter, and subjected to Western analysis both with
Ste3p-specific antibodies (top) and with the HA.11 monoclonal antibody
(bottom). The HA-Ura3p control provides the experiment with an internal
standard of a protein not subject to rapid turnover.
|
|
Two obvious candidates for the responsible a-specific gene
product are the
-factor receptor (Ste2p) and the a-factor pheromone. While deletion of the
-factor receptor structural gene
(STE2) is without consequence for the slowed Ste3p turnover seen in MATa cells (data not shown), deletion of the
two structural genes for a-factor, MFA1 and
MFA2, in fact restores rapid Ste3p turnover to these
MATa cells (Fig. 1). This finding could indicate that
the liganded receptor turns over more slowly. Alternatively, slowed
turnover could be a secondary consequence of pheromone response pathway
activation; forced expression of Ste3p in MATa cells
initiates an autocrine signaling loop (1). We were
interested to see, therefore, if added
-factor, acting through the
-factor receptor (Ste2p) of these MATa GAL1-STE3
mfa1
mfa2
cells, might compensate for the
a-factor deficiency. With the addition of
-factor, Ste3p
turnover is again slowed (Fig. 1), indicating that the slow turnover,
rather than being a direct consequence of a-factor binding,
is instead likely a secondary consequence of pheromone response pathway activation.
While the cell type-specific effect on Ste3p turnover could indicate
that endocytic mechanisms are deranged in cells responding to
pheromone, we thought it also might fit within the constellation of
phenotypes described for the STE3DAF allele
(13). The inhibition of the pheromone signaling pathway induced through the inappropriate expression of Ste3p in
MATa cells depends on the presence of at least one
a-specific gene product that is neither a-factor
nor Ste2p (13). If the impaired Ste3p turnover seen in
MATa cells also reflects an interaction with this
hypothetical a-specific gene product, then our results (Fig.
1) would indicate that this gene also is likely to be pheromone inducible.
ASG7.
Genome-wide analyses have identified
ASG7 as an a-specific gene that is strongly
induced by
-factor (24, 36). ASG7 encodes a
protein of 214 residues with two potential transmembrane domains
(Saccharomyces Genome Database). Asg7p shows no significant homology to other yeast or mammalian proteins. Below, we test if
ASG7 is the a-specific gene responsible for both
the STE3DAF phenotypes and slowed Ste3p turnover
in MATa cells.
MATa STE3DAF cells overcome the
terminal G1 arrest instigated by high doses of
-factor,
a mutational disabling of the G
subunit (a
gpa1ts mutation), or overproduction of the
G
subunit Ste4p (13). Haploid cells carrying
a GAL1-STE4 construct fail to plate on galactose medium
(Fig. 2): G
overproduction
is thought to allow escape of the G
component from
G
inhibition, thus activating the signaling pathway
(5, 21, 35). The Daf phenotype is apparent with introduction
of GAL1-STE3 into the GAL1-STE4 MATa cells,
i.e., robust growth is restored (Fig. 2). This suppression of
G1 arrest is a cell specific: MAT
GAL1-STE4 GAL1-STE3 cells grow quite poorly on galactose (Fig. 2).

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 2.
ASG7 is the a-specific gene
responsible for the Daf phenotype. Approximately 300 cells were spotted
onto rich YP plates containing either 2% glucose or 2% galactose and
allowed to grow for 2 days at 30°C. Cells from eight isogenic
strains SY2150, SY2560, SY2561, NDY1050, and NDY1077 (see Table 1
for genotypes), as well as SY2560, NDY1050, and NDY1078, transformed by
pND997 (pADH1-ASG7), a plasmid construct which
constitutively expresses ASG7 from the ADH1
promoter, were tested. The relevant features of the strain genotypes
are indicated to the left of growth spots.
|
|
To test if the suppression of G1 arrest mediated by Ste3p
in a cells requires ASG7, a
asg7
::G418R version of
the MATa GAL1-STE4 GAL1-STE3 strain was
constructed. With ASG7 disrupted, the strain failed to plate
to galactose medium (Fig. 2). The failed growth is due to failed
GAL1-STE4 repression and not to a requirement of
ASG7 for growth: in the absence of GAL1-STE4, the
asg7
mutation results in no growth defect in a or
cells growing on either galactose or glucose medium (data not
shown). We conclude that ASG7 is indeed the
a-specific gene that collaborates with Ste3p to suppress
activation of the pheromone response pathway.
As ASG7 expression is limited to a cells
(24, 36), we have constructed an ADH1-ASG7 allele
to examine the effects of ASG7 expression in the
-cell
context. Constitutive ASG7 expression, we find, is not
deleterious to cell growth in a or
cells (data not
shown). The ADH1-ASG7 allele complements asg7
:
introduction of the ADH1-ASG7 plasmid into MATa
GAL1-STE4 GAL1-STE3 asg7
cells restores growth on
galactose (Fig. 2). This suppression of GAL1-STE4 remains
dependent on Ste3p coexpression: the ADH1-ASG7 plasmid fails
to restore growth on galactose to MATa GAL1-STE4 asg7
cells (Fig. 2). In the MAT
context, forced
ASG7 expression restores robust growth on galactose medium
to MAT
GAL1-STE4 GAL1-STE3 cells (Fig. 2), indicating
that ASG7 indeed is the only a-specific gene
required for suppression of GAL1-STE4. Again, as in
a cells, suppression in
cells also depends on Ste3p
coexpression: the MAT
GAL1-STE4 ste3
ADH1-ASG7 strain
fails to grow on galactose (data not shown).
Coexpression of Asg7p and Ste3p blocks pheromone-induced
transcription.
We have examined the effects of Asg7p and Ste3p
coexpression on the
-factor-induced transcription of the
pheromone-inducible gene FUS1 by assessing
-galactosidase
levels induced from a FUS1-LacZ reporter construct. To
eliminate the potential for autocrine signaling through Ste3p,
mfa1
mfa2
MATa cells were used. Responses were
assessed over a 10,000-fold
-factor concentration range. Consistent
with the previous description of the Daf phenotype (13),
ectopic expression of Ste3p in MATa strongly impairs the
-factor response (Fig. 3; compare
GAL1-STE3 ASG7+ to ste3
ASG7+). Wild-type responsiveness is restored to
MATa GAL1-STE3 cells through ASG7
disruption (Fig. 3; see GAL1-STE3 asg7
), indicating again
that Ste3p and Asg7p together are required for the inhibition of
pheromone signaling. We have also investigated the effects of
constitutive expression of ASG7 from the
ADH1-ASG7 construct. In terms of FUS1-LacZ
induction, a much more pronounced inhibition was apparent:
MATa GAL1-STE3 ADH1-ASG7 cells failed to show a
detectable response to
-factor (Fig. 3). Again, this inhibition wholly depended on Ste3p coexpression (Fig. 3; see ste3
ADH1-ASG7). The difference between the responsiveness of
MATa GAL1-STE3 ADH1-ASG7 cells and that of
MATa GAL1-STE3 ASG7wt cells may be a
reflection of the initial levels of Asg7p present in the two types of
cells at the time of
-factor addition. ASG7 is strongly
inducible, and expression is virtually undetectable in
MATa cells unstimulated by pheromone (16, 24,
36). Inhibition of signaling in the GAL1-STE3
ASG7wt cells may await the new Asg7p that is
synthesized following the pheromone challenge. Indeed, a previous
kinetic analysis of the
-factor response of MATa
STE3DAF cells showed that inhibition of
signaling occurred only following an initial lag period: at early times
following
-factor addition, the response was found to be nearly wild
type (17). With constitutive Asg7p expression from the
ADH1 promoter, both Ste3p and Asg7p would be present in the
cell at the time of the
-factor challenge, possibly eliminating this
lag in the institution of the Asg7p-Ste3p repression.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 3.
Ste3p and Asg7p coexpression impairs the response to
-factor. -Galactosidase activity from a FUS1-LacZ
reporter construct was used as a measure of the -factor-induced
transcriptional response in six isogenic FUS1-LacZ bar1
STE2+ MATa strains: NDY1123, NDY1124, NDY1131,
NDY1172, NDY1173, and NDY1174 (see Table 1 for strain genotypes).
Cultures growing in YP-galactose (2%) medium were treated for 1 h
with 10 9, 10 8, 10 7,
10 6, or 10 5 M -factor or were mock
treated in parallel with no pheromone. Dose-response curves for induced
-galactosidase activity versus -factor concentration are shown.
As indicated to the right of each of the plots, the six strains differ
both at the STE3 locus, which is ste3 or
GAL1-STE3, and at the ASG7 locus, which is
wild-type ASG7, asg7 , or
ADH1-ASG7.
|
|
We conclude that Ste3p and Asg7p coexpression leads to a striking
inhibition of the pheromone response. However, in the absence of Ste3p
coexpression (the usual situation in a cells), we can
discern no effect of either ASG7 disruption or
overproduction on the cell's response to pheromone. Inhibition
requires the presence of both proteins. By itself, Asg7p has no
capacity for modulating the pheromone response.
Effects of Asg7p on Ste3p turnover and localization.
Next, we
examined if Asg7p is responsible for the slowed Ste3p turnover observed
in a cells (Fig. 1). MATa mfa1
mfa2
GAL1-STE3 cells that were either ASG7+ or
asg7
were treated with
-factor to induce
ASG7 expression, and Ste3p turnover was monitored (Fig.
4A). Disruption of ASG7 restores rapid turnover to these a cells, indicating that ASG7 is required for the slowed turnover previously observed
in a cells (Fig. 1). Furthermore, with expression of
ASG7 from the ADH1 promoter, slowed Ste3p
turnover is apparent in both the a- and
-cell contexts in
the absence of added pheromone (Fig. 4B and C), indicating that for the
slowed Ste3p turnover phenotype, pheromone is required simply for
establishing elevated levels of Asg7p within the cell and not for
activating Asg7p or Ste3p in some other way.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 4.
Asg7p is responsible for the slowed Ste3p turnover.
Ste3p turnover was assessed by Western blotting as in Fig. 1; the loss
of Ste3 antigen following the glucose repression of
GAL1-STE3 constructs was monitored. (A) ASG7
encodes the pheromone-inducible factor responsible for slowed Ste3p
turnover. The isogenic ASG7+ and asg7
MATa GAL1-STE3 mfa1 mfa2 strains SY2555 and
NDY1086 were cultured and treated with -factor or were mock treated
as described above for Fig. 1. (B) Constitutively expressed
ASG7 suffices to retard Ste3p turnover in a
cells. The isogenic asg7 , and ADH1-ASG7 MATa
GAL1-STE3 mfa1 mfa2 strains NDY1124 and NDY1131 were
cultured as described above for Fig. 1, except -factor treatment was
omitted. (C) Ectopic ASG7 expression in cells retards
Ste3p turnover. The GAL1-STE3 MAT SY2150 cells
transformed by the ADH1-ASG7 plasmid pND997 or by the
empty-vector plasmid (wt) were cultured as described for Fig. 1, except
-factor treatment was omitted.
|
|
Impaired turnover could reflect impaired Ste3p endocytosis.
Alternatively, Asg7p could act at a prior step. For instance, impaired
delivery of newly synthesized Ste3p to the cell surface also would have
the effect of slowing overall turnover. To test if Asg7p might act to
impair the secretory delivery of Ste3p to the cell surface, we compared
the rate at which the newly synthesized Ste3p truncation mutant
Ste3
365p arrives at the cell surface in MATa
GAL1-STE3
365 cells that were asg7
with that
in cells that were ADH1-ASG7. The
365 mutation removes
the signal for constitutive endocytosis; consequently, Ste3
365p does
not turn over and instead stably accumulates at the plasma membrane. Synthesis of Ste3
365p was induced with galactose addition, and the
rate of appearance at the cell surface was assessed using our standard
protease-shaving protocol (7, 27). For this, intact cells
are subjected to digestion by added, extracellular proteases; receptors
that localize to the plasma membrane are susceptible to digestion,
while receptors that localize intracellularly are resistant. Besides
causing the loss of plasma membrane-localized receptor proteins,
protease shaving results in the appearance of a characteristic 15-kDa
digestion product that corresponds to the protected cytoplasmic tail
domain plus the most C-terminal of the seven receptor transmembrane
domains (7). At the initial time point, 30 min following the
induction of synthesis, the bulk of the
365 receptor resisted
digestion in both the asg7
and ADH1-ASG7 cells
(Fig. 5A); presumably the bulk of the
newly synthesized receptor had yet to arrive at the plasma membrane. In
the asg7
background, with increasing time, an increasing
fraction of the total receptor population became available at the cell
surface for digestion (Fig. 5A). This is apparent at the 60-min time
point and is especially clear following a 30-min chase period in which continued receptor synthesis was shut down through glucose-mediated repression of the GAL1 promoter (Fig. 5A; the 90-min time
point): >90% of the receptor protein in wild-type cells now
resided at the plasma membrane. Quite a different outcome is observed
with the ADH1-ASG7 cells. Even following the 30-min
glucose chase period, only a small fraction of the receptor population
arrived at the cell surface (Fig. 5A). We conclude that Asg7p severely
disrupts Ste3
365p delivery to the cell surface. Thus, the impaired
turnover seen for Ste3p with Asg7p coexpression (Fig. 1 and 4) is
likely secondary to its impaired surface delivery; for endocytosis to commence, the receptor must first reach the plasma membrane.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 5.
Asg7p delays Ste3p delivery to the cell surface. A
60-min period of receptor expression from GAL1-STE3 365
was induced with galactose addition and terminated with the subsequent
addition of glucose. Cell growth was continued for an additional 30 min, affording the newly synthesized receptor the opportunity to reach
the cell surface. Culture aliquots at various time points were either
treated with proteases (+) or were mock treated in parallel ( ) (see
Materials and Methods). Protein extracts prepared from these cells were
subjected to Western analysis using Ste3p-specific antibodies. (A)
Constitutive ASG7 expression delays the delivery of Ste3p to
the cell surface in MATa cells. MATa
GAL1-STE3 365 mfa1 mfa2 cells, either
asg7 (NDY1125) or ADH1-ASG7 (NDY1141), were
cultured as described above. At 30 and 60 min following initiation of
the galactose-induced pulse and 30 min after the subsequent addition of
glucose (the 90-min time point), culture aliquots were removed for
protease shaving. Indicated at right are the positions both of the
undigested Ste3 365p receptor and of a receptor digestion product
corresponding to the protected cytoplasmic tail domain (CTD) plus the
most C-terminal of the seven receptor transmembrane domains. (B) The
Asg7p-mediated delay in Ste3p surface delivery occurs in
a/ diploid cells which do not express the subunits of the
heterotrimeric G protein. Localization of the Ste3 365p expressed in
MATa/ and MAT / cells cultured as
described above was assessed at the 90-min time point (following the
30-min glucose chase period) via the protease-shaving protocol. The
MATa/ strains used, NDY1176 and NDY1178, and the
MAT / strains used, NDY1185 and NDY1186, were
ASG7+/ASG7+ and
ADH1-ASG7/ASG7+, respectively. (Wild-type
ASG7 is expected to be transcriptionally silent in both
a/ and / contexts [24]). For
brevity, the portion of the gel displaying the lower-molecular-weight
CTD fragment is not shown. (C) The Asg7p-mediated delay in Ste3p
surface delivery occurs in cells with the G
subunit-encoding gene STE4 deleted. MAT
GAL1-STE3 365 cells (NDY1200) as well as MAT
GAL1-STE3 365 ADH1-ASG7 (NDY1204) and MAT
GAL1-STE3 365 ADH1-ASG7 ste4 ::LEU2 cells
(NDY1225) were cultured and treated with the protease-shaving protocol
as described for panel B.
|
|
Previous studies have indicated a central role for G
in the Daf phenotype (6, 17). We were interested to
investigate, therefore, G protein involvement in Asg7p inhibition of
Ste3p transport to the cell surface. For this, we investigated the
ability of Asg7p to block the surface delivery of Ste3
365p in the
MATa/
diploid cell context; in a/
cells, the three G protein subunits are transcriptionally repressed
(31). As a control, we constructed isogenic
/
pseudodiploids; like MATa or MAT
haploid
cells, MAT
/
cells are expected to express the G protein subunits. In the
/
cells, Asg7p coexpression was found to
retard the delivery of Ste3
365p to the cell surface (Fig. 5B) just
as it did in the MATa cell context (Fig. 5A). Identical effects are seen in the a/
context (Fig. 5B): Asg7p still retards Ste3
365p surface delivery, indicating a lack of
G protein requirement for this Asg7p action. Likewise, the introduction
of a ste4
mutation into MATa ADH1-ASG7
GAL1-STE3
365 cells also is without consequence for
Asg7p-mediated impaired delivery of Ste3p to the surface (Fig. 5C). For
the other Asg7p-Ste3p phenotype, i.e., inhibition of the pheromone
response, a similar assessment of G protein involvement is not possible
since the G proteins play a critical role in the experimental test
(e.g., either for FUS1-LacZ induction or for suppression of
GAL1-STE4). Nonetheless, the G protein independence
demonstrated in the present experiment (Fig. 5B and C) suggests the
possibility of direct interaction between Asg7p and Ste3p.
ASG7 and mating.
The striking phenotypes noted
above for ASG7 disruption or overproduction all involve the
artificial coexpression of Asg7p and Ste3p in the same cell. In
MATa cells not expressing STE3, both
ASG7 deletion and overexpression were without discernible effect on the FUS1 transcriptional response (Fig. 3).
Furthermore, we also find that asg7
and ADH1-ASG7
MATa cells show a morphogenetic response similar to that of
wild-type MATa cells following 3 h of treatment
with 10
5 M
-factor: normal mating projections were
observed (data not shown).
Table 2 shows mating efficiencies from
matings between wild-type
cells and either wild-type a
cells or the equivalent isogenic asg7
or
ADH1-ASG7 mutant. We discern no effect of either ASG7 disruption or overproduction on overall mating fitness.
The only clear effect of ASG7 status on mating occurred with
ASG7 expressed inappropriately in
cells (MAT
ADH1-ASG7); introduction of the ADH1-ASG7 allele into
the MAT
context blocked mating (Table 2). This cross, of
course, differs from the other matings in that one of the cells, the
cell, coexpresses both Ste3p and Asg7p. In such ADH1-ASG7
MAT
cells, two negative actions of Asg7p on mating are
anticipated: transport of Ste3p to the cell surface is expected to be
impaired, and, for receptors that are delivered to the surface,
signaling is expected to be blocked through the Asg7p-Ste3p repression
mechanism.
In addition to the matings reported in Table 2, we have also examined
the effects of the asg7
mutation in a variety of
different mating contexts that are known to reveal more subtle mating
defects. Defects in a variety of late-acting mating functions affecting the chemotropic response or zygotic cell fusion are often poorly revealed in matings to wild-type mating partners but can be accentuated in matings to impaired mating partners or when the mutant genes are
tested in synthetic combination with mutations in other genes affecting
these same processes (4, 8, 9). Such tests reveal striking
mating defects for mutations in a large number of functions, including
SPA2, AXL1, RVS161, FUS1,
FUS2, BNI1, SST2, and FAR1
(3, 8, 9, 11). As a first test, we introduced the
asg7
allele into sst2
or fus1
MATa cells; no added, synthetic defect was conferred by the
asg7 mutation (data not shown). We also tested the mating of
asg7
MATa cells to impaired partners, either
fus1
, sst2
or far1 MAT
cells.
While this approach has proved effective in uncovering subtle mating defects (4), again by this approach no defect was apparent for asg7
a cells (data not shown). Thus, by
these varied measures of mating, we can discern no significant
contribution of Asg7p to overall mating fitness.
Deranged zygotic morphology in asg7 matings.
We
have performed microscopic analysis of zygotes formed from matings
between wild-type MAT
cells and asg7
MATa cells (Fig. 6). Here, we
note several striking effects of the asg7
mutation. While
zygotes are formed with wild-type efficiency in the mating of wild-type
cells to asg7
a cells (Table 3), these new diploid cells show a
variety of morphologic abnormalities, often showing an unusual
protuberant structure at the midregion of the conjugation bridge that
connects the two cell bodies (Fig. 6). While approximately situated
where the first diploid mitotic bud normally emerges, this protrusion
does not show the neck-like constriction typical of emerging buds.
These novel structures can be detected at very early mating time points
(Fig. 6, 2.5-h time point) and often appear to be enlarged at later
time points (Fig. 6, 5-h time point), suggesting that these may
represent sites of aberrant polarized growth. Indeed, consistent with
this being a locus of cell growth, mitotic buds are often found to emerge from the tips of these protuberances at late time points, (Fig.
6, 5-h time point). Zygotes with these protrusions generally manifest
an overall bent morphology: instead of the linear dumbbell structure
typical of wild-type zygotes, the two mating partners often have the
aspect of having connected on an angle (Fig. 6). Finally, unlike the
zygotes derived from wild-type matings, very few of the zygotes derived
from early times of mating between wild-type MAT
and the
asg7
MATa cells are found with discernible emerging
mitotic buds.

View larger version (70K):
[in this window]
[in a new window]
|
FIG. 6.
Zygotes from asg7 matings are morphologically
deranged. Wild-type W303-1B MAT cells were mated to
either wild-type W303-1A MATa cells or the isogenic
asg7 strain NDY1089 for 2.5 or 5 h. Selected zygotes
visualized by Nomarski optics are shown. White arrows, new mitotic
buds; black arrows, stalk-like structures from the mitotic bud often
seen to emerge for asg7 zygotes.
|
|
In Table 3, we have quantified both the morphologic defect and budding
defect for asg7 zygotes, comparing zygotes from a fully
wild-type mating to zygotes from matings between wild-type MAT
cells and asg7
MATa cells.
Zygotes were classed as being normal or morphologically deranged. Only
zygotes with clear morphological derangements, displaying a midregion
protrusion and/or an overall bent morphology, were scored as abnormal.
From the asg7 matings a consistently high fraction of the
zygotes were classed as abnormal at each of the time points: at the 2-, 2.5-, and 3-h mating time points, 42, 57, and 63% of the zygotes,
respectively, were classed as abnormal. While similar derangements can
be found among zygotes from fully wild-type mating mixtures, these
occur at far lower frequencies (Table 3). Zygotes from matings of
wild-type
cells to a cells constitutively overexpressing
ASG7 from the ADH1 promoter were found to be
morphologically wild type (data not shown).
In addition to subclassing zygotes by morphology, we classed the same
zygotes as to whether a mitotic bud was displayed (Table 3). As this
analysis focuses on early mating time points (2 to 3 h), the
observed buds are expected to be the first buds to emerge from the new
zygotes. For wild-type zygotes, bud initiation is expected to begin
soon after cell fusion coincident with the G1-to-S transition. For the wild-type pairing at the early 2-h time point, discernible buds were identifiable on 21% of the new zygotes (Table 3). This fraction increased with time (Table 3, 2.5- and 3-h time
points), reflecting both new bud initiation and also continued growth
of preexisting buds (larger buds are more likely to be detected by our
microscopic analysis). For zygotes derived from the asg7
pairing, the emergence of this first mitotic bud was quite
significantly delayed (Table 3; compare the fraction of zygotes with
buds at the 2-, 2.5-, and 3-h time points for the wild-type and
asg7 matings). The delay in first bud emergence for the
asg7 zygotes could be secondary to the deranged morphology; for instance, derangement of the budding site could delay bud emergence. Alternatively, delayed budding could reflect a cell cycle
delay, with asg7 zygotes being slow to transition from
G1 to S.
Despite abnormal morphology and delayed budding, other aspects of the
zygotic developmental pathway appeared to proceed normally. Consistent
with the wild-type mating efficiency measured for asg7 matings (Table 2), zygotes arose from wild-type and asg7
mating mixtures at roughly equivalent frequencies (Table 3). In
addition, the kinetics of the zygotic cell fusion event was monitored
for the two matings. Zygotes were distinguished from prezygotes by monitoring the redistribution of a plasma membrane-localized GFP-Ras2p fusion protein present initially in just the
mating partner (8). Prezygotes, i.e., intermediates in which the two mating partners have attached but in which the intervening cell wall has not
yet been dissolved, localize the GFP fluorescence to just one of the
two partners (the
cell). With fusion, the fluorescence signal
rapidly distributes from the donor
cell throughout the entire cell
surface of the zygote. Following 2.5 h of mating, similar ratios
of prezygotes to zygotes from both wild-type and asg7
matings were found (see Table 5). Thus, the asg7
a cells are not fusion defective. In addition, we have used
the fluorescent DNA stain DAPI (4',6'-diamidino-2-phenylindole) to visualize nuclei and to monitor the congress of the two haploid nuclei
into the single diploid nucleus, i.e., karyogamy. No obvious defect in
karyogamy was observed for the asg7 zygotes; in general, the
vast majority of both the wild-type and asg7 zygotes
examined at early mating time points showed a single locus of DNA
staining localizing to the midsection of the conjugation bridge (data
not shown).
Epistasis of asg7 with fusion-defective mutations.
The linear dumbbell presentation of the wild-type zygote results from
tip-to-tip fusion of the two mating partners. The bent or angled
morphology seen for many of the asg7-derived zygotes (Fig.
6) suggested the possibility that the asg7
a
cells might be defective for this prezygotic connection to their
partners. Indeed, an angled connection between mating partners might
also account for the midpoint protuberance seen for the asg7
zygotes, with the protuberance being derived from the angled fusion of the two mating projections. We were interested therefore to examine the
morphology of prezygotes derived from asg7 pairings to see if the abnormalities seen for the zygotes are also present at this
early step.
Matings in which both partners are defective either for FUS1
or for FUS2 are blocked at the prezygote stage (20,
32). Mating partners stably connect through a process that
involves remodeling and fusion of exterior cell walls, but the
intervening cell wall between the two partners fails to be dissolved
and, consequently, cell and nuclear fusion fails to occur (3,
11). For matings between MAT
fus1
cells and
MATa fus1
cells or the equivalent
fus2
bilateral pairing, prezygotes accumulated with
kinetics similar to that seen for zygote accumulation in wild-type
matings (Table 4). In gross outline, the
prezygotes from either of these pairings generally resembled the linear
dumbbell structure typical of wild-type zygotes (not shown). To examine the effects of the asg7
mutation on prezygote morphology,
double-mutant MATa strains, either fus1
asg7
or fus2
asg7
, were constructed and then
tested in bilateral matings to the appropriate MAT
fus mutant. The morphologies of the prezygotes derived from these matings
were compared to those derived from the fusion-defective matings
involving ASG7+ MATa cells (Table 4). In
contrast to the severe effects of the asg7
mutation on
zygotic morphology (Fig. 6), we were not able to discern any effect on
prezygote morphology: no enhanced derangement was seen with the
introduction of asg7
into either the fus1 or
fus2 bilateral matings (Table 4). We conclude that the
fus1 and fus2 mutations are epistatic to
asg7
, suggesting that asg7-mediated
derangements are initiated at steps downstream of the zygotic fusion
event.
We have also examined the prezygotes which may be found as intermediate
structures in fusion-competent matings at early mating time points
(Table 5). Following 2.5 h of
mating, similar ratios of prezygotes to zygotes were found in both the
wild-type and asg7 matings (Table 5). While the zygotes from
the asg7 mating showed the usual array of deranged
morphologies, prezygotes examined from the same mating mixtures were
morphologically normal, indeed indistinguishable from the prezygotes
found in the wild-type mating mixtures (Table 5). Again, these results
indicate that the deranged morphology of the asg7 zygotes is
a consequence of events that occur subsequent to the fusion of the two
haploid cells.
 |
DISCUSSION |
Asg7p-Ste3p coexpression phenotypes.
We find that
ASG7 is the a-specific gene responsible for the
phenotype of the STE3DAF allele. Though defined
in a cells (13), the Daf phenotype, we also find,
may be reproduced in
cells with the forced, inappropriate expression of Asg7p in this context. Thus, Asg7p is the only
a-specific gene product and Ste3p is the only
-specific
gene product required for the inhibition. The key requirement for
inhibition is coexpression of Asg7p and Ste3p in the same cell. We also
report effects of ASG7 on Ste3p turnover and localization.
Asg7p slows Ste3p turnover (Fig. 4). However, instead of being a direct
result of Ste3p endocytosis, slowed turnover appears to be a secondary
consequence of the Asg7p-mediated inhibition of the secretory delivery
of Ste3p to the cell surface (Fig. 5).
The striking phenotypes described above depend on coexpression of Ste3p
and Asg7p in the same cell. While the strength and specificity of these
phenotypes argue for a functional linkage between these two proteins in
the mating process, the two proteins reside in distinct cell types and
thus are not normally available to one another. A possible explanation
for this paradox, offered by Hirsch and colleagues, is that the
response inhibition seen with STE3DAF MATa
cells recapitulates regulation that normally functions in the zygote
(17). The zygotic fusion event affords Ste3p the opportunity
to interact with its a-specific coinhibitor (now known to be
Asg7p). The inhibition provided by this interaction could be used to
shut down the pheromone response in the newly formed zygote, promoting
its transition to a vegetative mode of growth. As discussed below, our
results are nicely consistent with this model.
Asg7p-Ste3p inhibition in the zygote.
MATa
asg7
cells respond to pheromone normally and mate with
wild-type efficiency. However, while normal numbers of zygotes are
formed, the zygotes are morphologically deranged and show a delay to
the emergence of the first diploid mitotic bud. Since prezygotes
examined from these same matings are morphologically normal, we
concluded that perturbed zygotic morphology results from postfusion
events and not from an initially misoriented connection of the two
mating partners.
The two asg7 zygotic phenotypes, namely, deranged morphology
and delayed budding, may be explained in terms of aberrant growth patterns in the mutant zygote. In the wild-type zygotic developmental progression, following cell and nuclear fusion, the new zygote transitions out of G1 to S, DNA replication is initiated,
and a new mitotic bud begins to emerge from a central position in the
connecting conjugation bridge. For the asg7 zygote, delayed bud emergence and the aberrant morphology may be coupled. With delayed
bud initiation, ongoing growth of the cell must be channeled elsewhere,
perhaps into the bulge-like structure which emanates from the
approximate site where the first bud normally emerges (the conjugation
bridge). In overall aspect, the bulge somewhat resembles a growing
mating projection. A possibility, therefore, is that the
asg7 zygote is slow at making the transition from the
pheromone-stimulated growth pattern of haploid cells (i.e., mating
projection formation) to the vegetative, budding pattern of growth
characteristic of the new diploid cell. While slow, asg7
zygotes make this transition; the wild-type mating efficiency of
asg7
MATa cells (Table 2) indicates that the
resulting zygotes give rise to vegetatively growing colonies of diploid cells. Indeed, this transition is also apparent at the microscopic level; though the budding index of asg7 zygotes initially
lags behind that of wild-type zygotes, the asg7 budding
index increases sharply at later time points (Table 3). Thus, bud
initiation is delayed but not blocked for the asg7 zygotes.
In haploid cells responding to pheromone, maintenance of both the
G1 cell cycle arrest and the polarized pattern of cell
growth depends on continued pheromone signaling. Following successful fusion of the two mating partners, the reinitiation of the budding cycle requires that pheromone signaling be turned off. How is this
accomplished? Part of the answer may involve the known transcriptional changes that accompany the formation of the new a/
diploid genome. Many of the proteins that mediate pheromone signaling are haploid specific and are transcriptionally repressed in the a/
cell. Included in this set are the pheromones, the pheromone receptors, the subunits of the heterotrimeric G protein, and
several of the components of the downstream signaling cascade (31). With the loss of these proteins from the new diploid
cell, the capacity for signaling is blocked and the cell may then exit G1 and initiate budding. The rapidity of this transition
obviously should depend on the rate at which these signaling proteins
are removed, depending both on the rate at which the transcriptional repression is imposed and the rate at which preexisting proteins and
mRNA turn over. At the time of the zygotic fusion event, all these
proteins remain present and pheromone signaling is expected to be
intense. Layered onto the regulation provided by the a1/
2 transcriptional repression mechanism is a second, potentially more
rapid and effective means of shutting down signaling provided by Asg7p
and Ste3p, which gain access to one another through the zygotic fusion
event. The formation of an inhibitor from preexisting components
uniquely contributed from the two cell types provides a simple and
direct mechanism for shutting down signaling and terminating the mating
process once successful fusion has occurred.
Support for the hypothesis that Asg7p and Ste3p function together to
shut down signaling in the zygote is presently based in large part both
on the bud emergence delay observed for asg7 zygotes and on
our interpretation of the novel structure that emerges in these zygotes
as being a mating projection (and not a morphologically deranged
mitotic bud). Proof will await further experiments. Microarray analyses
should reveal if the pattern of gene expression in the newly formed
asg7 zygote is consistent with a failure to shut down
pheromone-induced gene expression. In addition, the expectation that
the G1-S transition is delayed for asg7 zygotes
will be directly tested by analyzing DNA content in new zygotes by flow cytometry.
Ste3p-Asg7p negative regulation of the pheromone response pathway may
function in other situations as well. In the mating type switching of
HO+ yeast cells, the newly switched cell is
expected to transiently express receptors and pheromones derived from
both mating types. Asg7p-Ste3p might serve to shut down this
unnecessary and potentially deleterious autocrine signaling. Along the
same lines, Asg7p-Ste3p inhibition likely provides at least part of the
explanation for the long-appreciated but poorly understood phenotype of
mat
2 mutant cells. mat
2 cells, which are
defective for repression of a-specific genes, constitutively
express both a- and
-cell-specific gene products (thus,
both Ste3p and Asg7p). In light of the present understanding of
Asg7p-Ste3p inhibition, it is not surprising that mat
2
mutants are severely impaired in their response to pheromone
(1).
Mechanism of Asg7p-Ste3p inhibition.
Little is understood
regarding the mechanism of Asg7p-Ste3p inhibition. From the present
analysis, it is clear that Ste3p is the only
-specific protein
required and Asg7p is the only a-specific protein required.
It is not clear if these two proteins physically interact. Furthermore,
it is not clear to what extent other proteins, present in both cell
types, participate.
While we have demonstrated that Ste3p delivery to the cell surface is
impaired in cells that express Asg7p, this mislocalization may not be
part of the natural zygotic regulatory mechanism. Both proteins are
membrane proteins and are expected to be initially inserted into the
endoplasmic reticulum (ER) following synthesis. With the artificial
coexpression of these two proteins in the same cell, an interaction
between newly synthesized Asg7p and Ste3p in the ER could be recognized
as inappropriate, with the consequence being Ste3p retention
(2). In the newly formed zygote, the interactions that
mediate the repressive effects on signaling would likely be between
preexisting, not newly synthesized, Asg7p and Ste3p. Nonetheless, an
aspect of the Asg7p-mediated inhibition of Ste3p surface delivery that
may be of wider significance in terms of the zygotic repression
mechanism is the G protein independence of this phenotype (Fig. 5B).
While the G
component likely is a central player for
Asg7p-Ste3p response inhibition (see the discussion below), the lack of
a G protein requirement for the Ste3p trafficking phenotype
demonstrates that Asg7p and Ste3p are capable of functionally
interacting in the absence of the G
subunit.
Previous work has indicated that the repression associated with the
STE3DAF allele (i.e., Asg7p-Ste3p repression) is
likely exerted on the signaling pathway at the level of the
G
component of the G protein (6, 13, 17).
Consistent with this, Kim et al. (16) have demonstrated that
a key part of the Asg7p-Ste3p repression mechanism is the
mislocalization of Ste4p away from the plasma membrane (its normal site
of action) to an intracellular locale. Significantly, Kim et al.
(16) also found a similar intracellular localization for a
functional Asg7p-GFP fusion, suggesting the possibility that Asg7p and
Ste4p may localize to the same intracellular compartment and that Asg7p
may act directly in the mislocalization of Ste4p. Indeed, our own
preliminary analyses of a functional HA epitope-tagged Asg7p expressed
in resting MATa cells from the GAL1
promoter reveal a clear localization both to the vacuolar membrane and
to perivacuolar compartments (data not shown). While Ste3p localization
has not been monitored in this context, Ste3p is known to traverse
similarly located endosomal compartments on its endocytic route to the
vacuole (7, 22). One possibility, therefore, is that Asg7p
increases the affinity of Ste3p for G
. Tight binding
may cause G
to be internalized together with the
endocytosed receptor. G
depletion from the plasma
membrane should block pheromone signal transduction (23).
Future studies will focus on the Asg7p-Ste3p repression mechanism. Do
Asg7p and Ste3p directly interact? Does Asg7p alter the interaction of
Ste3p with G
?
 |
ACKNOWLEDGMENTS |
We thank our colleagues Linyi Chen and Ying Feng for input and
support throughout the course of this work, and we thank Jeff Loeb for
the use of his microscope facility.
This work was supported by grants to C.B. from the National Science and
Engineering Council of Canada and from the National Cancer Institute of
Canada and by a grant to N.G.D. from the National Science Foundation
(MCB 99-06839).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Departments of
Surgery and Pharmacology, Wayne State University School of Medicine, Elliman Building, Room 1205, 421 E. Canfield, Detroit, MI 48201. Phone:
(313) 577-7807. Fax: (313) 577-7642. E-mail:
ndavis{at}cmb.biosci.wayne.edu.
 |
REFERENCES |
| 1.
|
Bender, A., and G. F. Sprague, Jr.
1989.
Pheromones and pheromone receptors are the primary determinants of mating specificity in the yeast Saccharomyces cerevisiae.
Genetics
121:463-476[Abstract/Free Full Text].
|
| 2.
|
Bonifacino, J. S., and A. M. Weissman.
1998.
Ubiquitin and the control of protein fate in the secretory and endocytic pathways.
Annu. Rev. Cell Dev. Biol.
14:19-57[CrossRef][Medline].
|
| 3.
|
Brizzio, V.,
A. E. Gammie, and M. D. Rose.
1998.
Rvs161p interacts with Fus2p to promote cell fusion in Saccharomyces cerevisiae.
J. Cell Biol.
141:567-584[Abstract/Free Full Text].
|
| 4.
|
Chenevert, J.,
N. Valtz, and I. Herskowitz.
1994.
Identification of genes required for normal pheromone-induced cell polarization in Saccharomyces cerevisiae.
Genetics
136:1287-1296[Abstract].
|
| 5.
|
Cole, G. M.,
D. E. Stone, and S. I. Reed.
1990.
Stoichiometry of G protein subunits affects the Saccharomyces cerevisiae mating pheromone signal transduction pathway.
Mol. Cell. Biol.
10:510-517[Abstract/Free Full Text].
|
| 6.
|
Couve, A., and J. P. Hirsch.
1996.
Loss of sustained Fus3p kinase activity and the G1 arrest response in cells expressing an inappropriate pheromone receptor.
Mol. Cell. Biol.
16:4478-4485[Abstract].
|
| 7.
|
Davis, N. G.,
J. L. Horecka, and G. F. Sprague, Jr.
1993.
Cis- and trans-acting functions required for endocytosis of the yeast pheromone receptors.
J. Cell Biol.
122:53-65[Abstract/Free Full Text].
|
| 8.
|
Dorer, R.,
C. Boone,
T. Kimbrough,
J. Kim, and L. H. Hartwell.
1997.
Genetic analysis of default mating behavior in Sacchar |